|
|
||||||||
Gastrointestinal Imaging |
1 From the Diagnostic Radiology Department, Warren Grant Magnuson Clinical Center (N.A.A., A.J.D.), and the PulmonaryCritical Care Medical Branch, National Heart, Lung, and Blood Institute (J.A.K., S.C.C., J.M.), National Institutes of Health, Bldg 10, Rm 1C-660, 10 Center Dr MSC 1182, Bethesda, MD 20892-1182. Received May 18, 1999; revision requested October 1; final revision received November 1; accepted November 10. Address correspondence to N.A.A. (e-mail: navila@nih.gov).
PURPOSE: To describe the abdominal computed tomographic (CT) and ultrasonographic (US) findings in patients with thoracic lymphangioleiomyomatosis (LAM) and to relate the prevalence of the findings to the severity of pulmonary disease.
MATERIALS AND METHODS: Eighty patients with LAM underwent chest and abdominopelvic CT and abdominopelvic US. The images were reviewed prospectively by one radiologist, and the abdominal findings were recorded and correlated with the severity of pulmonary disease at thin-section CT.
RESULTS: Sixty-one (76%) of 80 patients had positive abdominal findings. The most common abdominal findings included renal angiomyolipoma (AML) in 43 patients (54%), enlarged abdominal lymph nodes in 31 (39%), and lymphangiomyoma in 13 (16%). Less common findings included ascites in eight (10%), dilatation of the thoracic duct in seven (9%), and hepatic AML in three (4%). A significant correlation (P = .02) was observed between enlarged abdominal lymph nodes and increased severity of lung disease.
CONCLUSION: There are characteristic abdominal findings in patients with LAM that, in conjunction with the classic thin-section CT finding of pulmonary cysts, are useful in establishing this diagnosis.
Index terms: Angiomyolipoma, 81.3141 Kidney neoplasms, CT, 81.12111, 81.12112, 81.3141, 81.3199 Kidney neoplasms, US, 81.1298, 81.3141, 81.3199 Liver neoplasms, 761.3141 Lung, CT, 60.12111, 60.12112, 60.319, 60.829 Lung, diseases, 60.799 Lymphangiomyomatosis, 993.829 Lymphatic system, CT, 99.12911, 99.12912, 99.12918 Lymphatic system, US, 99.12983, 99.12984
This article has been cited by other articles:
![]() |
S. Harari, R. Cassandro, J. Chiodini, A. M. Taveira-DaSilva, and J. Moss Effect of a Gonadotrophin-Releasing Hormone Analogue on Lung Function in Lymphangioleiomyomatosis Chest, February 1, 2008; 133(2): 448 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P Cosgrove, S. K Frankel, and K. K Brown Challenges in pulmonary fibrosis {middle dot} 3: Cystic lung disease Thorax, September 1, 2007; 62(9): 820 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Attili and E. A. Kazerooni Case 116: Lymphangioleiomyomatosis Radiology, July 1, 2007; 244(1): 303 - 308. [Full Text] [PDF] |
||||
![]() |
N. A. Avila, A. J. Dwyer, A. Rabel, and J. Moss Sporadic Lymphangioleiomyomatosis and Tuberous Sclerosis Complex with Lymphangioleiomyomatosis: Comparison of CT Features Radiology, December 1, 2006; 242(1): 277 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Johnson Lymphangioleiomyomatosis. Eur. Respir. J., May 1, 2006; 27(5): 1056 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Goncharova, D. A. Goncharov, P. N. Lim, D. Noonan, and V. P. Krymskaya Modulation of Cell Migration and Invasiveness by Tumor Suppressor TSC2 in Lymphangioleiomyomatosis Am. J. Respir. Cell Mol. Biol., April 1, 2006; 34(4): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. H. Ryu, J. Moss, G. J. Beck, J.-C. Lee, K. K. Brown, J. T. Chapman, G. A. Finlay, E. J. Olson, S. J. Ruoss, J. R. Maurer, et al. The NHLBI Lymphangioleiomyomatosis Registry: Characteristics of 230 Patients at Enrollment Am. J. Respir. Crit. Care Med., January 1, 2006; 173(1): 105 - 111. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Astrinidis and E. Petri Henske Aberrant Cellular Differentiation and Migration in Renal and Pulmonary Tuberous Sclerosis Complex J Child Neurol, September 1, 2004; 19(9): 710 - 715. [Abstract] [PDF] |
||||
![]() |
J. A. Whitsett, C. J. Bachurski, K. C. Barnes, P. A. Bunn Jr., L. M. Case, D. N. Cook, D. Crooks, M. W. Duncan, L. Dwyer-Nield, R. C. Elston, et al. Functional Genomics of Lung Disease Am. J. Respir. Cell Mol. Biol., August 1, 2004; 31(2/S1): S1 - S81. [Full Text] [PDF] |
||||
![]() |
J. Yu, A. Astrinidis, S. Howard, and E. P. Henske Estradiol and tamoxifen stimulate LAM-associated angiomyolipoma cell growth and activate both genomic and nongenomic signaling pathways Am J Physiol Lung Cell Mol Physiol, April 1, 2004; 286(4): L694 - L700. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Wong, T.-K. Yeung, and W. C.-W. Chu Atypical Presentation of Lymphangioleiomyomatosis as Acute Abdomen: CT Diagnosis Am. J. Roentgenol., July 1, 2003; 181(1): 284 - 285. [Full Text] [PDF] |
||||
![]() |
M. Karbowniczek, A. Astrinidis, B. R. Balsara, J. R. Testa, J. H. Lium, T. V. Colby, F. X. McCormack, and E. P. Henske Recurrent Lymphangiomyomatosis after Transplantation: Genetic Analyses Reveal a Metastatic Mechanism Am. J. Respir. Crit. Care Med., April 1, 2003; 167(7): 976 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Pallisa, P. Sanz, A. Roman, J. Majo, J. Andreu, and J. Caceres Lymphangioleiomyomatosis: Pulmonary and Abdominal Findings with Pathologic Correlation RadioGraphics, October 1, 2002; 22(90001): S185 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Avila, J. Bechtle, A. J. Dwyer, V. J. Ferrans, and J. Moss Lymphangioleiomyomatosis: CT of Diurnal Variation of Lymphangioleiomyomas Radiology, November 1, 2001; 221(2): 415 - 421. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |